Therapeutic Strategy for Metformin-Associated Lactic Acidosis
- PMID: 33731621
- DOI: 10.1097/CCM.0000000000004805
Therapeutic Strategy for Metformin-Associated Lactic Acidosis
Conflict of interest statement
The authors have disclosed that they do not have any potential conflicts of interest.
Comment in
-
The authors reply.Crit Care Med. 2021 Apr 1;49(4):e461-e462. doi: 10.1097/CCM.0000000000004901. Crit Care Med. 2021. PMID: 33731622 No abstract available.
Comment on
-
A Study of Associations Between Plasma Metformin Concentration, Lactic Acidosis, and Mortality in an Emergency Hospitalization Context.Crit Care Med. 2020 Dec;48(12):e1194-e1202. doi: 10.1097/CCM.0000000000004589. Crit Care Med. 2020. PMID: 33003077
References
-
- Bennis Y, Bodeau S, Batteux B, et al. A Study of Associations Between Plasma Metformin Concentration, Lactic Acidosis, and Mortality in an Emergency Hospitalization Context. Crit Care Med. 2020; 48:e1194–e1202
-
- DeFronzo R, Fleming GA, Chen K, et al. Metformin-associated lactic acidosis: Current perspectives on causes and risk. Metabolism. 2016; 65:20–29
-
- Seidowsky A, Nseir S, Houdret N, et al. Metformin-associated lactic acidosis: A prognostic and therapeutic study. Crit Care Med. 2009; 37:2191–2196
-
- Calello DP, Liu KD, Wiegand TJ, et al. Extracorporeal Treatments in Poisoning WorkgroupExtracorporeal treatment for metformin poisoning: Systematic review and recommendations from the extracorporeal treatments in poisoning workgroup. Crit Care Med. 2015; 43:1716–1730
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
